Microfluidics meets metabolomics to reveal the impact of Campylobacter jejuni infection on biochemical pathways
Biomedical Microdevices, ISSN: 1572-8781, Vol: 18, Issue: 3, Page: 51
2016
- 13Citations
- 36Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations13
- Citation Indexes13
- 13
- CrossRef12
- Captures36
- Readers36
- 36
Article Description
Microfluidic devices that are currently being used in pharmaceutical research also have a significant potential for utilization in investigating exposure to infectious agents. We have established a microfluidic device cultured with Caco-2 cells, and utilized metabolomics to investigate the biochemical responses to the bacterial pathogen Campylobacter jejuni. In the microfluidic devices, Caco-2 cells polarize at day 5, are uniform, have defined brush borders and tight junctions, and form a mucus layer. Metabolomics analysis of cell culture media collected from both Caco-2 cell culture systems demonstrated a more metabolic homogenous biochemical profile in the media collected from microfluidic devices, compared with media collected from transwells. GeneGo pathway mapping indicated that aminoacyl-tRNA biosynthesis was perturbed by fluid flow, suggesting that fluid dynamics and shear stress impacts the cells translational quality control. Both microfluidic device and transwell culturing systems were used to investigate the impact of Campylobacter jejuni infection on biochemical processes. Caco-2 cells cultured in either system were infected at day 5 with C. jejuni 81–176 for 48 h. Metabolomics analysis clearly differentiated C. jejuni 81–176 infected and non-infected medias collected from the microfluidic devices, and demonstrated that C. jejuni 81–176 infection in microfluidic devices impacts branched-chain amino acid metabolism, glycolysis, and gluconeogenesis. In contrast, no distinction was seen in the biochemical profiles of infected versus non-infected media collected from cells cultured in transwells. Microfluidic culturing conditions demonstrated a more metabolically homogenous cell population, and present the opportunity for studying host-pathogen interactions for extended periods of time.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84971222509&origin=inward; http://dx.doi.org/10.1007/s10544-016-0076-9; http://www.ncbi.nlm.nih.gov/pubmed/27231016; http://link.springer.com/10.1007/s10544-016-0076-9; https://dx.doi.org/10.1007/s10544-016-0076-9; https://link.springer.com/article/10.1007/s10544-016-0076-9; http://link.springer.com/content/pdf/10.1007/s10544-016-0076-9.pdf; https://link.springer.com/content/pdf/10.1007/s10544-016-0076-9.pdf; http://link.springer.com/article/10.1007%2Fs10544-016-0076-9; https://link.springer.com/content/pdf/10.1007%2Fs10544-016-0076-9.pdf; http://link.springer.com/article/10.1007/s10544-016-0076-9/fulltext.html; http://link.springer.com/content/pdf/10.1007/s10544-016-0076-9; https://rti.pure.elsevier.com/en/publications/2ddfe975-b83b-449f-b5b8-9c62077735cc
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know